Budget & Taxes (Tax Credits)

SB 51 increases the research and development (R&D) tax credit exchange rate to 100% specifically for biotechnology companies in Connecticut. This change directly affects biotech firms by allowing them to claim the full value of eligible R&D expenses as a tax credit against state tax liability. The bill amends Section 12-217ee of the general statutes to implement this rate increase, replacing any previous lower credit rate for this industry. The policy change provides a concrete financial incentive to support biotech research and development activities within the state.

SB 69 would eliminate Connecticut's Earned Income Tax Credit (EITC) by repealing the statute (section 12-704e) that created the program. This change would directly affect low-to-moderate income working individuals and families, particularly those with children, who currently qualify for the credit. The bill's key mechanism is the simple repeal of the existing law, removing the eligibility and calculation rules for the credit. As a result, qualifying residents would no longer receive this refundable tax credit, reducing their annual tax refund or increasing their tax liability. The bill does not create new provisions but removes the current program.